• February 22, 2019
• 0

AbbVie and Voyager Therapeutics have entered into an exclusive global strategic collaboration and option agreement to develop and commercialise vectorised antibodies for the potential treatment of Parkinson's disease. The deal means that Voyager...

• February 21, 2019
• 0

Pfizer and Eli Lilly have revealed more positive results for their non-opioid pain drug tanezumab - with significant improvements in chronic lower pack pain (CBLP). The results come from a phase III...

• February 21, 2019
• 0

Abbott and Novo Nordisk have begun a non-exclusive partnership to provide integrated digital solutions for patients with diabetes requiring insulin. The collaboration enables insulin data to be shared between Novo...

• February 20, 2019
• 0

New molecules developed at Toronto's Centre for Addiction and Mental Health have shown signifcant promise in their ability to reverse memory loss associated with depression and ageing. Not only do these molecules improve cognitive...

• February 19, 2019
• 0

British biotech Gyroscope Therapeutics may have stumbled onto a gold mine if its new gene therapy for the most common form of blindness proves effective. The company is currently treating...

• February 15, 2019
• 0

Merck Sharpe & Dohme is setting its sights to expand Keytruda for the treatment of prostate cancer, developing it further as an already robust leader in lung cancer. Merck is now currently...

• February 14, 2019
• 0

British biotech firm Bicycle Therapeutics is set to develop a new class of antibacterial agents to tackle the growing problem of antimicrobial resistance (AMR) with a £496,000 government grant. Bicycle Therapeutics...

• February 11, 2019
• 0

Mutations caused by oesophageal adenocarcinoma (OAC) have been mapped in unprecedented detail, unveiling that around half of all cases could be targeted by drugs already in clinical trials. The research...

• February 8, 2019
• 0

A Massachusetts Institute of Technology (MIT) led team have developed a drug capsule that can be used to deliver oral doses of insulin, potentially removing the necessity of daily injections...

• February 8, 2019
• 0

A completely novel type of oncology drug that acts in the same fashion as a 'Trojan horse' to get inside tumour cells has shown significant promise in patients with six different cancer types....